Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/zhimeng-biopharma-cb03-received-orphan-drug-designation-from-the-us-fda---a-potassium-ion-channel-opener-for-amyotrophic-lateral-sclerosis-301962939.html
https://www.prnewswire.com/news-releases/zhimeng-biopharma-will-report-positive-phase-1b-trial-results-on-its-hbv-capsid-inhibitor-zm-h1505r-in-the-upcoming-international-liver-congress-301567111.html
https://www.asiaone.com/business/zhimeng-biopharma-announces-dosing-first-subject-its-novel-antiepileptic-drug-candidate
https://www.prnewswire.com/news-releases/zhimeng-biopharma-announces-dosing-of-first-subject-of-its-novel-antiepileptic-drug-candidate-cb03-in-first-in-human-phase-i-clinical-trial-301544760.html
https://www.prnewswire.com/news-releases/zhimeng-biopharma-announces-dosing-of-first-subject-in-first-in-human-phase----clinical-trial-of-cb06-301515047.html